For franchisors whose model relies heavily on technology, software, operational systems or bespoke equipment, enforceability ...

As 2026 begins, we find ourselves reflecting on the dynamic landscape of Life Sciences and Healthcare regulations over the ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...

Great Britain is entering a new era of MedTech regulation, with major pre-market changes expected that are designed to ...

In June 2025, the Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024 came ...

Fieldfisher partner John Worthy wins two new awards: Fieldfisher partner and head of Satellite and Space Projects John Worthy ...

The Takeover Panel’s Code Committee published a response statement (RS 2025/1) on 2 December 2025, outlining amendments to ...

In the high-stakes realm of corporate M&A, negotiations governing the period between signing (exchange) and completion is ...

The automatic suspension of contract-making is a unique feature of procurement litigation.  When a claim is issued against a ...

European law firm Fieldfisher has further strengthened its regulatory offering in the Brussels office with the arrival of ...

Here’s a quick recap of how Polish merger control and FDI worked in 2025 and an outline of the potential implications for ...

After months of uncertainty, December saw a surge in deal activity, signalling renewed confidence across prime office, ...